000 01175 a2200313 4500
005 20250514211745.0
264 0 _c20050322
008 200503s 0 0 eng d
022 _a1474-175X
024 7 _a10.1038/nrc1501
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBesson, Arnaud
245 0 0 _aRegulation of the cytoskeleton: an oncogenic function for CDK inhibitors?
_h[electronic resource]
260 _bNature reviews. Cancer
_cDec 2004
300 _a948-55 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aCell Division
650 0 4 _aCyclin-Dependent Kinases
_xantagonists & inhibitors
650 0 4 _aCytoskeleton
_xdrug effects
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xenzymology
650 0 4 _aSignal Transduction
650 0 4 _arho GTP-Binding Proteins
_xmetabolism
700 1 _aAssoian, Richard K
700 1 _aRoberts, James M
773 0 _tNature reviews. Cancer
_gvol. 4
_gno. 12
_gp. 948-55
856 4 0 _uhttps://doi.org/10.1038/nrc1501
_zAvailable from publisher's website
999 _c15258355
_d15258355